Red blood cell transfusion in clinical practice

Lancet

Volumn 370, Issue 9585, 2007, Pages 415-426

  Klein, Harvey G ^a   Spahn, Donat R ^b   Carson, Jeffrey L ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; BIOCHEMISTRY; BLOOD; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD EXAMINATION; BLOOD GROUP TYPING; BLOOD STORAGE; BLOOD VOLUME; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMPENSATION; DEVELOPING COUNTRY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; HEPATITIS VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPOXEMIA; IMMUNITY; INFECTION; INTENSIVE CARE; LABORATORY TEST; MEDICAL LITERATURE; OXYGEN TRANSPORT; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY FUNCTION; REVIEW; SCREENING; TISSUE OXYGENATION;

EID: 34547408352     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61197-0     Document Type: Review

References (176)

1. Blundell J. Some account of a case of obstinate vomiting in which an attempt was made to prolong life by the injection of blood into the veins. Med Chir Trans 10 (1818) 310-312
2. Landsteiner K. Uber Agglutinationserscheinungen normalen menschlichen Blutes. Klin Wschr 14 (1901) 1132
3. Robertson O. Transfusion with preserved red blood cells. Brit Med J i (1918) 691
4. Hess J., and Schmidt P. The first blood banker: Oswald Hope Robertson. Transfusion 40 (2000) 110-113
5. American Association of Blood Banks. Technical Manual (15 edn) (2005), AABB Press, Bethesda
6. American Association of Blood Banks. Standards for blood banks and transfusion services (2005), AABB Press, Bethesda
7. Guidelines for the Blood Transfusion Services in the United Kingdom. 7th edn. (2005), TSO, London
8. Strauss R., Burmeister L., Johnson K., Cress G., and Cordle D. Feasibility and safety of AS-3 red blood cells for neonatal transfusions. J Pediatr 136 (2000 February) 215-219
9. Walker R. Mathematical calculations in transfusion medicine. Clin Lab Med 16 (1996) 895-906
10. Klein H., and Anstee D. Mollison's Blood transfusion in Clinical Medicine. 11 edn. (2005), Blackwell Publishing, Oxford
11. Strumia M., Dugan A., Taylor L., Strumia P., and Bassert D. Splenectomy in leukemia and myelofibrosis-changes in the erythrocyte values. Am J Clin Pathol 37 (1962) 491-498
12. Morris K., Naqvi N., Davies P., Smith M., and Lee P. A new formula for blood transfusion volume in the critically ill. Arch Dis Child 90 (2005) 724-728
13. Gabrio B., and Finch C. Erythrocyte preservation I: the relation of the storage lesion to in vivo erythrocyte senescence. J Clin Invest 33 (1954) 242-246
14. Dern R., Brewer G., and Wiorkowski J. Studies on the preservation of human blood. II. The relationship of erythrocyte adenosine triphosphate levels and other in vitro measures to red cell storageability. J Lab Clin Med 69 (1967) 968-978
15. Greenwalt T., Bryan D., and Dumaswala U. Erythrocyte membrane vesiculation and changes in membrane composition during storage in citrate-phosphate-dextrose-adenine-1. Vox Sang 47 (1984) 261-270
16. Rumsby M., Trotter J., Allan D., and Michell R. Recovery of membrane micro-vesicles from human erythrocytes stored for transfusion: a mechanism for the erythrocyte discocyte-to-spherocyte shape transformation. Biochem Soc Trans 5 (1977) 126-128
17. Latham Jr. J., Bove J., and Weirich F. Chemical and hematologic changes in stored CPDA-1 blood. Transfusion 22 (1982) 158-159
18. Beutler E., and Kuhl W. Volume control of erythrocytes during storage. The role of mannitol. Transfusion 28 (1988) 353-357
19. Greenwalt T., Zehner Sostok C., and Dumaswala U. Studies in red blood cell preservation 2-comparison of vesicle formation, morphology, and membrane lipids during storage in AS-1 and CPDA-1. Vox Sang 58 (1990) 90-93
20. Silliman C., Clay K., Thurman G., Johnson C., and Ambruso D. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 124 (1994) 684-694
21. Chanutin A., and Curnish R. Effect of organic phosphates on the O2 equilibrium of carboxypeptidase digests of human hemoglobin. Arch Biochem Biophys 123 (1968) 163-165
22. Beutler E., Meul A., and Wood L. Depletion and regeneration of 2,3-diphosphoglyceric acid in stored red blood cells. Transfusion 9 (1969) 109-115
23. Valeri C., and Hirsch N. Restoration in vivo of erythrocyte adenosine triphosphate, 2,3-diphosphoglycerate, potassium ion, and sodium ion concentrations following the transfusion of acid-citrate-dextrose-stored human red blood cells. J Lab Clin Med 73 (1969) 722-733
24. Purdy F., Tweeddale M., and Merrick P. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 44 (1997) 1256-1261
25. Offner P., Moore E., Biffl W., Johnson J., and Silliman C. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg 137 (2002) 711-716
26. Klein H. Getting older is not necessarily getting better. Anesthesiology 98 (2003) 807-808
27. Silliman C., Voelkel N., Allard J., et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 101 (1998) 1458-1467
28. Marik P., and Sibbald W. Effect of stored-blood transfusion on O2 delivery in patients with sepsis. JAMA 269 (1993) 3024-3029
29. Walsh T., McArdle F., McLellan S., et al. Does the storage time of transfused red blood cells influence regional or global indexes of tissue O2ation in anemic critically ill patients?. Crit Care Med 32 (2004) 364-371
30. Weiskopf R., Feiner J., Hopf H., et al. Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology 104 (2006) 911-920
31. Butch S., and Judd W. Requirements for the computer crossmatch. Transfusion 34 (1994) 187
32. Buehler P., and Alayash A. Oxygen sensing in the circulation: "cross talk" between red blood cells and the vasculature. Antioxid Redox Signal 6 (2004) 1000-1010
33. Tsai A., Cabrales P., Hangai-Hoger N., and Intaglietta M. Oxygen distribution and respiration by the microcirculation. Antioxid Redox Signal 6 (2004) 1011-1018
34. Hsia C. Respiratory function of hemoglobin. N Engl J Med 338 (1998) 239-247
35. Beasley R., McNaughton A., and Robinson G. New look at the oxyhaemoglobin dissociation curve. Lancet 367 (2006) 1124-1126
36. Howarth S., and Sharpey-Schafer E. Low blood pressure phases following haemorrhage. Lancet 1 (1947) 18-20
37. Skillman J., Lauler D., Hickler R., et al. Hemorrhage in normal man: effect on renin, cortisol, aldosterone, and urine composition. Ann Surg 166 (1967) 865-885
38. Skillman J., Awwad H., and Moore F. Plasma protein kinetics of the early transcapillary refill after hemorrhage in man. Surg Gynecol Obstet 125 (1967) 983-996
39. Meyers R., Paulick R., Rudolph C., and Rudolph A. Cardiovascular responses to acute, severe haemorrhage in fetal sheep. J Dev Physiol 15 (1991) 189-197
40. Kreuzer F. Facilitated diffusion of O2 and its possible significance; a review. Respir Physiol 9 (1970) 1-30
41. Weiskopf R., Viele M., Feiner J., et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 279 (1998) 217-221
42. van Woerkens E., Trouwborst A., Duncker D., Koning M., Boomsma F., and Verdouw P. Catecholamines and regional hemodynamics during isovolemic hemodilution in anesthetized pigs. J Appl Physiol 72 (1992) 760-769
43. Moss G., DeWoskin R., Rosen A., Levine H., and Palani C. Transport of O2 and carbon dioxide by hemoglobin-saline solution in the red cell-free primate. Surg Gynecol Obstet 142 (1976) 357-362
44. van der Linden P., De Hert S., Mathieu N., et al. Tolerance to acute isovolemic hemodilution. Effect of anesthetic depth. Anesthesiology 99 (2003) 97-104
45. Jamnicki M., Kocian R., van der Linden P., Zaugg M., and Spahn D. Acute normovolemic hemodilution: physiology, limitations, and clinical use. J Cardiothorac Vasc Anesth 17 (2003) 747-754
46. Morisaki H., and Sibbald W. Tissue O2 delivery and the microcirculation. Crit Care Clin 20 (2004) 213-223
47. Spahn D., Leone B., Reves J., and Pasch T. Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of non O2-carrying and O2-carrying solutions. Anesth Analg 78 (1994) 1000-1021
48. Habler O., Kleen M., Podtschaske A., et al. The effect of acute normovolemic hemodilution (ANH) on myocardial contractility in anesthetized dogs. Anesth Analg 83 (1996) 451-458
49. Ickx B., Rigolet M., and Van Der Linden P. Cardiovascular and metabolic response to acute normovolemic anemia. Effects of anesthesia. Anesthesiology 93 (2000) 1011-1016
50. Spahn D., Schmid E., Seifert B., and Pasch T. Hemodilution tolerance in patients with coronary artery disease who are receiving chronic beta-adrenergic blocker therapy. Anesth Analg 82 (1996) 687-694
51. Spahn D., Zollinger A., Schlumpf R., et al. Hemodilution tolerance in elderly patients without known cardiac disease. Anesth Analg 82 (1996) 681-686
52. Madjdpour C., and Spahn D. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth 95 (2005) 33-42
53. van der L., Schmartz D., De G., et al. Critical haemoglobin concentration in anaesthetized dogs: comparison of two plasma substitutes. Br J Anaesth 81 (1998) 556-562
54. Cain S. Oxygen delivery and uptake in dogs during anemic and hypoxic hypoxia. J Appl Physiol 42 (1977) 228-234
55. Rasanen J. Supply-dependent O2 consumption and mixed venous oxyhemoglobin saturation during isovolemic hemodilution in pigs. Chest 101 (1992) 1121-1124
56. Trouwborst A., Tenbrinck R., and van Woerkens E. Blood gas analysis of mixed venous blood during normoxic acute isovolemic hemodilution in pigs. Anesth Analg 70 (1990) 523-529
57. van B., Trouwborst A., Schwarte L., Siegemund M., Ince C., and Henny C. Intestinal and cerebral O2ation during severe isovolemic hemodilution and subsequent hyperoxic ventilation in a pig model. Anesthesiology 97 (2002) 660-670
58. Pearce F., Waasdorp C., Hufnagel H., et al. Subcutaneous PO2 as an index of the physiological limits for hemodilution in the rat. J Appl Physiol 99 (2005) 814-821
59. van Woerkens E., Trouwborst A., and van Lanschot J. Profound hemodilution: what is the critical level of hemodilution at which O2 delivery-dependent O2 consumption starts in an anesthetized human?. Anesth Analg 75 (1992) 818-821
60. Lieberman J., Weiskopf R., Kelley S., et al. Critical O2 delivery in conscious humans is less than 7·3 ml O2 × kg (-1) × min(-1). Anesthesiology 92 (2000) 407-413
61. Weiskopf R., Kramer J., Viele M., et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 92 (2000) 1646-1652
62. Weiskopf R., Feiner J., Hopf H., et al. Oxygen reverses deficits of cognitive function and memory and increased heart rate induced by acute severe isovolemic anemia. Anesthesiology 96 (2002) 871-877
63. Casutt M., Seifert B., Pasch T., Schmid E., Turina M., and Spahn D. Factors influencing the individual effects of blood transfusions on O2 delivery and O2 consumption. Crit Care Med 27 (1999) 2194-2200
64. Moia M., Mannucci P., Vizzotto L., Casati S., Cattaneo M., and Ponticelli C. Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet 2 (1987) 1227-1229
65. Valeri C., Cassidy G., Pivacek L., et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 41 (2001) 977-983
66. Spahn D., and Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth 95 (2005) 130-139
67. Adams R., and Lundy J. Anesthesia in cases of poor risk. Some suggestions for decreasing the risk. Surg Gynecol Obstet 74 (1942) 1011-1019
68. Friedman B., Burns T., and Schork M. An analysis of blood transfusion of surgical patients by sex: a question for the transfusion trigger. Transfusion 20 (1980) 179-188
69. Klein H. Blood avoidance for the critically ill: another blow to liberalism?. Crit Care Med 34 (2006) 2013-2014
70. Crowell J., and Smith E. Determinant of the optimal hematocrit. J Appl Physiol 22 (1967) 501-504
71. Vincent J., Baron J., Reinhart K., et al. Anemia and blood transfusion in critically ill patients. JAMA 288 (2002) 1499-1507
72. Rao M., Boralessa H., Morgan C., et al. Blood component use in critically ill patients. Anaesthesia 57 (2002) 530-534
73. Shapiro M., Gettinger A., Corwin H., et al. Anemia and blood transfusion in trauma patients admitted to the intensive care unit. J Trauma 55 (2003) 269-273
74. English M., Ahmed M., Ngando C., Berkley J., and Ross A. Blood transfusion for severe anaemia in children in a Kenyan hospital. Lancet 359 (2002) 494-495
75. Nelson A., Fleisher L., and Rosenbaum S. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 21 (1993) 860-866
76. Carson J., Duff A., Poses R., et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 348 (1996) 1055-1060
77. Wu W., Rathore S., Wang Y., Radford M., and Krumholz H. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 (2001 October 25) 1230-1236
78. Johansson P., Hansen M., and Sorensen H. Transfusion practice in massively bleeding patients: time for a change?. Vox Sang 89 (2005) 92-96
79. Hebert P., Wells G., Blajchman M., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340 (1999) 409-417
80. Hebert P., Blajchman M., Cook D., et al. Do blood transfusions improve outcomes related to mechanical ventilation?. Chest 119 (2001) 1850-1857
81. Lacroix J., Hébert P., Hutchison J., et al. Transfusion requirements for patients in paediatric intensive care units. N Engl J Med 365 (2007) 1609-1619
82. Guralnik J., Eisenstaedt R., Ferrucci L., Klein H., and Woodman R. The prevalence of anemia in persons age 65 and older in the United States: evidence for a high rate of unexplained anemia. Blood 104 (2004) 2263-2268
83. Bierbaum B., Callaghan J., Galante J., Rubash H., Tooms R., and Welch R. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 81 (1999) 2-10
84. Henry D., Carless P., Moxey A., et al. Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2 (2002) CD003602.
85. Popovsky M., Whitaker B., and Arnold N. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 35 (1995) 734-737
86. Linden J., and Kruskall M. Autologous blood: always safer?. Transfusion 37 (1997) 455-456
87. McVay P., Andrews A., Hoag M., et al. Moderate and severe reactions during autologous blood donations are no more frequent than during homologous blood donations. Vox Sang 59 (1990) 70-72
88. Goldman M., Remy-Prince S., Trepanier A., and Decary F. Autologous donation error rates in Canada. Transfusion 37 (1997) 523-527
89. Segal J., Blasco-Colmenares E., Norris E., and Guallar E. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 44 (2004) 632-644
90. Carless P., Henry D., Moxey A., O'Connell D., and Fergusson D. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 4 (2003) CD001888.
91. Huber T., McGorray S., Carlton L., et al. Intraoperative autologous transfusion during elective infrarenal aortic reconstruction: a decision analysis model. J Vasc Surg 25 (1997) 984-993
92. Alvarez G., Fergusson D., Neilipovitz D., and Hebert P. Cell salvage does not minimize perioperative allogeneic blood transfusion in abdominal vascular surgery: a systematic review. Can J Anaesth 51 (2004) 425-431
93. Giordano G., Wallace B., Rivers S., et al. Intraoperative autotransfusion: a community program. Hosp Health Serv Adm 35 (1990) 139-148
94. Topley E., and Fischer M. The illness of trauma. Br J Clin Pract 1 (1956) 770-776
95. Fortune J., Feustel P., Saifi J., Stratton H., Newell J., and Shah D. Influence of hematocrit on cardiopulmonary function after acute hemorrhage. J Traum 27 (1987) 243-249
96. Johnson R., Thurer R., Kruskall M., et al. Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Cardiovasc Surg 104 (1992) 307-314
97. Bush R., Pevec W., and Holcroft J. A Prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. Am J Surg 174 (1997) 143-148
98. Carson J., Terrin M., Barton F., Aaron R., Greenburg A., Heck D., et al. A pilot randomized trial comparing symptomatic vs. hemoglobin- level-driven red blood cell transfusions following hip fracture. Transfusion 38 (1998) 522-529
99. Lotke P., Barth P., Garino J., and Cook E. Predonated autologous blood transfusions after total knee arthroplasty: immediate versus delayed administration. Journal of Arthroplasty 14 6 (1999 September) 647-650
100. Bracey A., Radovancevic R., Riggs S., et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 39 (1999) 1070-1077
101. Carson J., Duff A., Berlin J., et al. Perioperative blood transfusion and postoperative mortality. JAMA 279 (1998) 199-205
102. Spiess B., Ley C., Body S., et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. J Thorac Cardiovasc Surg 116 (1998) 460-467
103. Fan F.-C., Chen R., Schuessler G., and Chien S. Effects of hematocrit variations on regional hemodynamics and O2 transport in the dog. Am J Physiol 238 (1980) 545-552
104. Finch C., and Lenfant C. Oxygen transport in man. N Engl J Med 286 (1972) 407-415
105. Murray J., and Rapaport E. Coronary blood flow and myocardial metabolism in acute experimental anaemia. Cardiovasc Res 6 (1972) 360-367
106. Jan K.-M., and Chien S. Effect of hematocrit variations on coronary hemodynamics and O2 utilization. Am J Physiol 233 (1977) 106-113
107. Wilkerson D., Rosen A., Sehgal L., Gould S., Sehgal H., and Moss G. Limits of cardiac compensation in anemic baboons. Surgery 103 (1988) 665-670
108. Hogue C., Goodnough L., and Monk T. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion 38 (1998) 924-931
109. Licker M., Sierra J., Tassaux D., and Diaper J. Continuous haemodynamic monitoring using transoesophageal Doppler during acute normovolaemic haemodilution in patients with coronary artery disease. Anaesthesia 59 (2004) 108-115
110. Licker M., Ellenberger C., Sierra J., Christenson J., Diaper J., and Morel D. Cardiovascular response to acute normovolemic hemodilution in patients with coronary artery diseases: Assessment with transesophageal echocardiography. Crit Care Med 33 (2005) 591-597
111. Hebert P., Yetisir E., Martin C., et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?. Crit Care Med 29 (2001) 227-234
112. Rao S., Jollis J., Harrington R., et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 (2004) 1555-1562
113. Sabatine M., Morrow D., Giugliano R., et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 (2005) 2042-2049
114. Spahn D., Smith L., Veronee C., et al. Acute isovolemic hemodilution and blood transfusion-effects on regional function and metabolism in myocardium with compromised coronary blood flow. J Thorac Cardiovasc Surg 105 (1993) 694-704
115. Chapler C., and Cain S. The physiologic reserve in O2 carrying capacity: studies in experimental hemodilution. Can J Physiol Pharmacol 64 (1986) 7-12
116. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group. BMJ 300 (1990) 573-578
117. Rizzo J., Lichtin A., Woolf S., et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood 100 (2002) 2303-2320
118. Cazzola M., Borgna-Pignatti C., Locatelli F., Ponchio L., Beguin Y., and De S. A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion 37 (1997) 135-140
119. Vichinsky E., Haberkern C., Neumayr L., et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 333 (1995) 206-213
120. Koshy M., Weiner S., Miller S., et al. Surgery and anesthesia in sickle cell disease. Blood 86 (1995) 3676-3684
121. Adams R., McKie V., Hsu L., et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 339 (1998) 5-11
122. Vichinsky E., Neumayr L., Earles A., Williams R., Lennette E., Dean D., et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 342 25 (2000 June 22) 1855-1865
123. Koshy M., Burd L., Wallace D., Moawad A., and Baron J. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study. N Engl J Med 319 (1988) 1447-1452
124. Vichinsky E., Luban N., Wright E., et al. Prospective RBCs phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 41 (2001) 1086-1092
125. Klein H. Pathogen inactivation technology: cleansing the blood supply. J Intern Med 257 (2005) 224-237
126. Mayer K. A different view of transfusion safety--type and screen, transfusion of Coombs incompatible cells, and fatal transfusion-induced graft versus host disease. In: Polesky H., and Walker R. (Eds). Safety in transfusion practices (1982), College of American Pathologists, Skokie
127. Linden J., Wagner K., Voytovich A., and Sheehan J. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion 40 (2000) 1207-1213
128. Dzik W., Murphy M., Andreu G., et al. An international study of the performance of sample collection from patients. Vox Sang 85 (2003) 40-47
129. Davies A., Staves J., Kay J., Casbard A., and Murphy M. End-to-end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses. Transfusion 46 (2006) 352-364
130. Dzik W. Technology for enhanced transfusion safety. Hematology Am Soc Hematol Educ Program (2005) 476-482
131. Lostumbo M., Holland P., and Schmidt P. Isoimmunization after multiple transfusions. N Engl J Med 275 (1966) 141-144
132. Schonewille H., van de Watering L., Loomans D., and Brand A. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion 46 (2006) 250-256
133. Pineda A., Vamvakas E., Gorden L., Winters J., and Moore S. Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion 39 (1999) 1097-1103
134. Ness P., Shirey R., Thoman S., and Buck S. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion 30 (1990) 688-693
135. Hillman N. Fatal delayed hemolytic transfusion reaction due to anti-c + E. Transfusion 19 (1979) 548-551
136. Menitove J., McElligott M., and Aster R. Febrile transfusion reaction: what blood component should be given next?. Vox Sang 42 (1982) 318-321
137. Lane T., Gernsheimer T., Mohandas K., and Assmann S. Signs and symptoms associated with the transfusion of WBC-reduced RBCss and non-WBC-reduced RBCss in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion 42 (2002) 265-274
138. Brittingham T., and Chaplin Jr. H. Febrile transfusion reactions caused by sensitivity to donor leucocytes and platelets. JAMA 165 (1957) 819-825
139. Kleinman S., Caulfield T., Chan P., et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 44 (2004) 1774-1789
140. Popovsky M., and Haley N. Further characterization of transfusion-related acute lung injury: demographics, clinical and laboratory features, and morbidity. Immunohematol 17 (2001) 157-159
141. Popovsky M., and Moore S. Autologous transfusion in Jehovah's Witnesses. Transfusion 25 (1985) 444
142. Stephen C., Martin R., and Bourgeois-Gavardin M. Antihistaminic drugs in treatment of nonhemolytic transfusion reactions. JAMA 158 (1955) 525-529
143. Domen R., and Hoeltge G. Allergic transfusion reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med 127 (2003) 316-320
144. Pineda A., and Taswell H. Transfusion reactions associated with anti-IgA antibodies: report of four cases and review of the literature. Transfusion 151 (1975) 10-15
145. Koda Y., Watanabe Y., Soejima M., et al. Simple PCR detection of haptoglobin gene deletion in anhaptoglobinemic patients with antihaptoglobin antibody that causes anaphylactic transfusion reactions. Blood 95 (2000) 1138-1143
146. Sandler S., Trimble J., and Mallory D. Coexistent IgG2 and IgA deficiencies in blood donors. Transfusion 36 (1996) 256-258
147. Hathaway W., Githens J., Blackburn W., Fulginiti V., and Kempe C. Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children. Probable human runt disease. N Engl J Med 273 (1965) 953-958
148. Ohto H., and Anderson K. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfus Med Rev 10 (1996) 31-43
149. von F V., Higby D., and Kim U. Graft-versus-host reaction following blood product transfusion. Am J Med 72 (1982) 951-961
150. Anderson K., and Weinstein H. Transfusion-associated graft-versus-host disease. N Engl J Med 323 (1990) 315-321
151. Guide to the preparation, use, and quality assurance of blood components. 11 edn. (2005), Council of Europe Publishing, Strasbourg
152. Klein H. Transfusion-associated graft-versus-host disease: less fresh blood and more gray (Gy) for an aging population. Transfusion 46 (2006) 878
153. Opelz G., Sengar D., Mickey M., and Terasaki P. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5 (1973) 253-259
154. Busch O., Hop W., van Papendrecht M.H., Marquet R., and Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 328 (1993) 1372-1376
155. Amato A., and Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 1 (2006) CD005033.
156. Heiss M., Mempel W., Delanoff C., et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 12 (1994) 1859-1867
157. Blajchman M. Transfusion immunomodulation or TRIM: what does it mean clinically?. Hematology 10 suppl 1 (2005) 208-214
158. Jensen L., Puho E., Pedersen L., Mortensen F., and Sorensen H. Long-term survival after colorectal surgery associated with buffy-coat-poor and leucocyte-depleted blood transfusion: a follow-up study. Lancet 365 (2005) 681-682
159. van de Watering L., Brand A., Houbiers J., Kranenbarg W.K., Hermans J., and van d V. Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. Br J Surg 88 (2001) 267-272
160. Klein H. Immunomodulatory aspects of transfusion: a once and future risk?. Anesthesiology 91 (1999) 861-865
161. Popovsky M., Moore S., Wick M., Devine P., Pineda A., and Taswell H. A blood bank consultation service: principles and practice. Mayo Clin Proc 60 (1985) 312-314
162. Popovsky M., Audet A., and Andrzejewski Jr. C. Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study. Immunohematol 12 (1996) 87-89
163. Sweeney J., Dupuis M., and Mega A. Hypotensive reactions to red cells filtered at the bedside, but not to those filtered before storage, in patients taking ACE inhibitors. Transfusion 38 (1998) 410-411
164. Arnold D., Molinaro G., Warkentin T., et al. Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage. Transfusion 44 (2004) 1361-1366
165. Lavee J., and Paz Y. Hypotensive reactions associated with transfusion of bedside leucocyte-reduction filtered blood products in heart transplanted patients. J Heart Lung Transplant 20 (2001) 759-761
166. Olivieri N., Nathan D., MacMillan J., et al. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 331 (1994) 574-578
167. Brittenham G., Griffith P., Nienhuis A., et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 331 (1994) 567-573
168. Borgna-Pignatti C., Rugolotto S., De S., et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89 (2004) 1187-1193
169. Ley T., and Nienhuis A. Chelation therapy for transfusion-dependent adults. N Engl J Med 308 (1983) 1422-1423
170. Harmatz P., Butensky E., Quirolo K., et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood 96 (2000) 76-79
171. Hashmi G., Shariff T., Seul M., et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 45 (2005) 680-688
172. Clewley J. A role for arrays in clinical virology: fact or fiction?. J Clin Virol 29 (2004) 2-12
173. Murad K., Mahany K., Brugnara C., Kuypers F., Eaton J., and Scott M. Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood 93 (1999) 2121-2127
174. Olsson M., Hill C., de la Vega H., et al. Universal red blood cells--enzymatic conversion of blood group A and B antigens. Transfus Clin Biol 11 (2004) 33-39
175. Giarratana M., Kobari L., Lapillonne H., et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 23 (2005) 69-74
176. Spahn D., and Kocian R. Artificial O2 carriers: status in 2005. Curr Pharm Des 11 (2005) 4099-4114